Beta-blockers are a class of drugs used to control symptoms of heart failure that are made worse by certain hormones called catecholamines. The body releases these hormones as part of its response to heart failure. For this and other reasons, beta-blockers have been shown to be effective for treating most people who have heart failure.
Beta-blockers have a variety of effects throughout the body. They are used to treat heart disease that causes chest pain, high blood pressure, heart attacks, and cardiomyopathy and irregular, rapid heartbeats (arrhythmia). Beta-blockers are also used to prevent migraine headaches, treat tremors, and control anxiety.
Bisoprolol, carvedilol, and metoprolol are some of the beta-blockers that have been tested for use in the treatment of heart failure.
With diastolic heart failure, the heart does not have enough time to relax and fill with blood before pumping it out to the rest of your body. Beta-blockers help treat diastolic heart failure because they slow the heart rate and allow more time for your heart to fill with blood. Then, your heart can pump more blood with each heartbeat.
Certain beta-blockers have been shown to:1
Beta-blockers may sometimes cause a drop in blood pressure when a person stands up (orthostatic hypotension), resulting in dizziness and, rarely, fainting.
If you have diabetes and take beta-blockers, watch your blood sugar levels closely to prevent low-sugar episodes (hypoglycemia). For some people, beta-blockers can hide symptoms of low blood sugar (hypoglycemia).
Beta-blockers may also slightly increase cholesterol levels.
The effect of beta-blockers may depend on the dosage used. A lower dose may have a different effect than a higher dose. Beta-blocker therapy is typically started at a low dose and increased slowly over time.
It may take a few months to see the effects of beta-blocker medicine.
Beta-blockers have been used for many years to treat high blood pressure (hypertension).
Citations
- Hunt SA, et al. (2009). 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 119(14): e391–e479.
| By | Healthwise Staff |
|---|---|
| Primary Medical Reviewer | E. Gregory Thompson, MD - Internal Medicine |
| Specialist Medical Reviewer | Theresa O'Young, PharmD - Clinical Pharmacy |
| Last Revised | August 9, 2010 |
Next Section:
Related InformationPrevious Section:
Topic OverviewNext Section:
ReferencesPrevious Section:
Related InformationNext Section:
CreditsPrevious Section:
ReferencesLast Revised: August 9, 2010
Author: Healthwise Staff
Medical Review: E. Gregory Thompson, MD - Internal Medicine & Theresa O'Young, PharmD - Clinical Pharmacy
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Seton is proud to have four hospitals – the only hospitals in Central Texas - that have earned the Magnet designation, the highest award for nursing excellence given by the American Nurses Association.
